Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma
- 1 September 2012
- journal article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 143 (2), 680-685
- https://doi.org/10.1016/j.jep.2012.07.025
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Municipal Bureau of Health Fund, China (2009103)
This publication has 35 references indexed in Scilit:
- Extracts from Citrus unshiu promote immune-mediated inhibition of tumor growth in a murine renal cell carcinoma modelJournal of Ethnopharmacology, 2011
- Chemosensitization of tumors by resveratrolAnnals of the New York Academy of Sciences, 2011
- NF‐κB as a potential molecular target for cancer therapyBioFactors, 2007
- Active Antitumor Immunity Elicited by Vaccine Based on Recombinant Form of Epidermal Growth Factor ReceptorJournal of Immunotherapy, 2005
- Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal periodThe Journal of Experimental Medicine, 2005
- Antidiabetic herbal drugs officially approved in ChinaPhytotherapy Research, 2003
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- The Epidermal Growth Factor Receptor Engages Receptor Interacting Protein and Nuclear Factor-κB (NF-κB)-inducing Kinase to Activate NF-κBPublished by Elsevier BV ,2001
- Cell Adhesion Molecules in the Development and Progression of Malignant MelanomaCancer and Metastasis Reviews, 1999
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984